Effect of Enteral Nutrition on In-hospital Infection and Hospital Expense in Stroke Patients: A Retrospective Assessment.
enteral nutrition
infection
medical expense
stroke
Journal
Neurologia medico-chirurgica
ISSN: 1349-8029
Titre abrégé: Neurol Med Chir (Tokyo)
Pays: Japan
ID NLM: 0400775
Informations de publication
Date de publication:
15 Apr 2021
15 Apr 2021
Historique:
pubmed:
12
3
2021
medline:
29
10
2021
entrez:
11
3
2021
Statut:
ppublish
Résumé
Infection is a common complication of stroke and is associated with unfavorable outcomes. Although nutritional intervention reduces the risk of postoperative infection, the impact of specific nutritional products remains unclear. From a hospital management perspective, we aimed to determine whether the provision of specific types of enteral nutrition in acute stroke patients affects infection control and hospital costs. In all, 45 acute hemorrhagic stroke patients receiving enteral nutrition in a single center (April 2017-March 2019) were retrospectively assessed. Patients were divided into two groups according to nutritional interventions: the 1.0-group with general nutrition (1.0 kcal/mL) (24 patients) and the 1.5+α-group with an initial high-protein, whey peptide-digested liquid diet (1.5 kcal/mL), followed by a highly fermentable fiber-containing liquid diet (1.5 kcal/mL initiated after 4 days) (21 patients). Changes in body mass index (BMI), duration of antibiotic use, incidence of postoperative infection, and medical cost were evaluated. Baseline patient characteristics were similar between groups. The mean BMI change was lower in the 1.5+α-group than in the 1.0-group, and the mean duration of antibiotic use throughout hospitalization was 12.8 and 18.3 days, respectively. Antibiotic use in the 1.5+α-group was lesser than that in Japanese patients from other hospitals. The incidence of postoperative infections was lower in the 1.5+α-group. Injection costs for the 1.5+α group (615 USD/patient) were lower than those for the 1.0-group. Enteral nutrition provided to acute stroke patients reduced the risk of hospital infection and medical costs.
Identifiants
pubmed: 33692283
doi: 10.2176/nmc.oa.2020-0350
pmc: PMC8048121
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
268-274Références
Lancet. 2015 Nov 7;386(10006):1835-44
pubmed: 26343840
Clin Nutr. 2017 Aug;36(4):1089-1096
pubmed: 27426415
Stroke. 2007 Feb;38(2 Suppl):770-3
pubmed: 17261736
J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):297-304
pubmed: 23160703
Japan Med Assoc J. 2012 Jul;55(4):279-91
pubmed: 25237234
BMC Neurol. 2018 Mar 7;18(1):23
pubmed: 29514600
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
J Clin Neurosci. 2015 Sep;22(9):1473-6
pubmed: 26183306
J Med Food. 2005 Spring;8(1):113-6
pubmed: 15857221
Immunity. 2018 May 15;48(5):992-1005.e8
pubmed: 29768180
Lancet. 2015 Apr 18;385(9977):1519-26
pubmed: 25612858
BMC Neurol. 2011 Sep 20;11:110
pubmed: 21933425
Br J Nutr. 2004 Jul;92(1):105-11
pubmed: 15230993